CMV

COMMUNIQUÉS West-GlobeNewswire

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
14/08/2025
CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second [...]
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025
Live video webcast on Wednesday, August 20 th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative [...]
Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025
Live video webcast on Tuesday, August 19th at 2:20 PM ET SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company [...]
Akari Therapeutics to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025
Live video webcast on Tuesday, August 19th at 2:00 PM ET BOSTON and LONDON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing novel Antibody Drug Conjugates ( [...]
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025
– Live video webcast on Wednesday, August 20 th at 2:00 PM ET HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with [...]
NIH Contract Expands DLH’s Position as a Digital Transformation and Cybersecurity Leader
14/08/2025
Company to Continue Providing Information Technology Services for National Institutes of Health ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider [...]
À l’occasion de la Journée mondiale du don d’organes, le KFSHRC annonce la réalisation de 10 greffes de reins croisées en 48 heures
14/08/2025
RIYAD, Arabie saoudite, 14 août 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSHRC) a réalisé avec succès 10 greffes de reins croisées en deux jours consécutifs, établissant ainsi le [...]
Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm™ (epinephrine) Sublingual Film
14/08/2025
Anaphylm launch funding of $75 million committed by RTW, subject to FDA approval of Anaphylm and other conditions Strategic financing will further strengthen the Company’s balance sheet in advance of potential [...]
Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation
14/08/2025
Oslo, Norway, 14 August 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, invites you to a webcast presentation [...]
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
14/08/2025
~ Achieved Second Quarter 2025 Total Net Revenues of $9.7 Million ~ ~ Double Digit New Accounts in the Second Quarter of 2025, Including Notable Quarter-Over-Quarter Growth in Both Large Community Practices and Academic [...]
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
14/08/2025
WARREN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives [...]
Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights
14/08/2025
– Submitted Investigational New Drug (IND) application to evaluate SL-325 in a Phase 1 clinical trial in healthy volunteers; clearance expected in Q3 2025 – – On track to dose first participant in Phase 1 clinical trial [...]
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
14/08/2025
Planned strategic combination with Beckley Psytech expected to solidify position as global leader in transformative, psychedelic-based mental health therapies with a short time in-clinic Reported positive topline data [...]
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
14/08/2025
PRT7732, once daily oral SMARCA2 degrader, currently enrolling at the seventh dosing cohort (125 mg); Company to provide an update with preliminary clinical data, including PK/PD, safety and initial clinical activity by [...]
Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements
14/08/2025
NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the [...]
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
14/08/2025
Exton, Pa., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical Inc. , a medical technology company focused on neurostimulation therapies for critically ill patients, today announced that the Centers for Medicare & [...]
Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025
14/08/2025
BOTHELL, Wash., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow [...]
Balt USA Responds to Patent Infringement Lawsuit Filed by Route 92 Medical
14/08/2025
IRVINE, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Balt USA, LLC (“Balt”), a global leader in neurovascular medical devices, today announced it intends to vigorously defend against the allegations of patent infringement [...]
Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
14/08/2025
– WTX-124 Phase 1/1b clinical trial on track for interim data readout in the fourth quarter of 2025, including patients in both the monotherapy and combination expansion arms of cutaneous melanoma and renal cell [...]

Pages